US equities |
NVDA $241.46 ▲+1.07% SPCX $173.62 ▲+1.48% MU $1,064.79 ▲+0.08% AMD $656.17 ▲+3.87% MRVL $289.00 ▲+6.54% SNDK $1,675.42 ▼-1.69% AVGO $378.10 ▲+4.30% TSLA $381.31 ▲+0.68%
FinancialContent

Revvity, Inc. Common Stock (NY:RVTY)

153.61 -3.75 (-2.38%)
Delayed Quote Updated: 11:31 AM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revvity, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Revvity to Host Investor Day
From Revvity
Via Business Wire
News headline image
Revvity to Hold Earnings Call on November 3, 2026
From Revvity
Via Business Wire
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗
Via Chartmill
News headline image
Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings?
Revvity has been on fire lately. In the past six months alone, the company’s stock price has rocketed 78%, reaching $150.93 per share. This was partly due to... 
Via StockStory
News headline image
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
Via StockStory
Topics Supply Chain
Revvity (NYSE:RVTY) Beats Q2 EPS Estimates, but Soft Revenue Guidance Caps Stock Reaction ↗
Via Chartmill
Discover which S&P500 stocks are making waves on Thursday. ↗
Via Chartmill
News headline image
Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes
From Revvity
Via Business Wire
News headline image
1 Momentum Stock with Promising Prospects and 2 Facing Headwinds
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne... 
Via StockStory
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
Discover which S&P500 stocks are making waves on Tuesday. ↗
Via Chartmill
News headline image
Q2 Rundown: Revvity (NYSE:RVTY) Vs Other Research Tools & Consumables Stocks
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the research tools & consumables industry,... 
Via StockStory
Topics Economy
News headline image
3 Healthcare Stocks That Fall Short
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme... 
Via StockStory
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery
From Revvity
Via Business Wire
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
3 Hyped Up Stocks We Find Risky
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab... 
Via StockStory
Topics Retirement
News headline image
Revvity (RVTY) Q2 2026 Earnings Call Transcript ↗
Diagnostics surged 11% organically as AI-driven demand accelerated. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
News headline image
The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call
Revvity’s second quarter demonstrated year-over-year growth in both revenue and non-GAAP earnings, yet the market responded negatively, likely reflecting con... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
Revvity Q2 Earnings Call Highlights ↗
Revvity (NYSE:RVTY) reported second-quarter results above its expectations and raised its full-year outlook, citing continued strength in diagnostics, improving demand from pharmaceutical and... 
Via MarketBeat
Topics Earnings
News headline image
1 Profitable Stock on Our Buy List and 2 We Find Risky
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
Why Revvity (RVTY) Stock Is Up Today
What Happened? Shares of life sciences company Revvity (NYSE:RVTY) jumped 3.1% in the afternoon session after the company reported strong second-quarter 2026... 
Via StockStory
News headline image
RVTY Q2 Deep Dive: AI-Driven Demand and Diagnostics Growth Shape Outlook
Life sciences company Revvity (NYSE:RVTY) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 4.5% year on year to $711.1 millio... 
Via StockStory
Topics Artificial Intelligence
These S&P500 stocks are moving in today's session ↗
Via Chartmill
Discover which S&P500 stocks are making waves on Tuesday. ↗
Via Chartmill
Gapping S&P500 stocks in Tuesday's session ↗
Via Chartmill
News headline image
Transcript: Revvity Q2 2026 Earnings Conference Call ↗
Revvity (NYSE:RVTY) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and... 
Via Benzinga
Topics Earnings
News headline image
Revvity (NYSE:RVTY) Reports Upbeat Q2 CY2026
Life sciences company Revvity (NYSE:RVTY) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 7.2% year on year to $729.7 mil... 
Via StockStory
News headline image
Revvity Announces Financial Results for the Second Quarter of 2026
From Revvity
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >